Immunotherapy: Seek and destroy: oncolytic virus shows promise in phase I trial
- PMID: 21931354
- DOI: 10.1038/nrclinonc.2011.143
Immunotherapy: Seek and destroy: oncolytic virus shows promise in phase I trial
Comment on
-
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.Nature. 2011 Aug 31;477(7362):99-102. doi: 10.1038/nature10358. Nature. 2011. PMID: 21886163 Clinical Trial.
References
-
- Nature. 2011 Aug 31;477(7362):99-102 - PubMed
Publication types
LinkOut - more resources
Full Text Sources